Gross Profit Summary of Masimo Corporation

Masimo Corporation's latest annual gross profit in 2023 was 1 Billion USD , down -5.22% from previous year.
Masimo Corporation's latest quarterly gross profit in 2024 Q3 was 263.2 Million USD , up 3.3% from previous quarter.
Masimo Corporation reported a annual gross profit of 1.05 Billion USD in annual gross profit 2022, up 30.98% from previous year.
Masimo Corporation reported a annual gross profit of 808.34 Million USD in annual gross profit 2021, up 8.79% from previous year.
Masimo Corporation reported a quarterly gross profit of 241.7 Million USD for 2024 Q1, down -7.99% from previous quarter.
Masimo Corporation reported a quarterly gross profit of 254.8 Million USD for 2024 Q2, up 5.42% from previous quarter.

Annual Gross Profit Chart of Masimo Corporation (2023 - 1998)

Historical Annual Gross Profit of Masimo Corporation (2023 - 1998)

Year	Gross Profit	Gross Profit Growth
2023	1 Billion USD	-5.22%
2022	1.05 Billion USD	30.98%
2021	808.34 Million USD	8.79%
2020	743.06 Million USD	18.1%
2019	629.17 Million USD	9.44%
2018	574.89 Million USD	7.44%
2017	535.1 Million USD	15.37%
2016	463.79 Million USD	13.13%
2015	409.98 Million USD	4.91%
2014	390.77 Million USD	8.9%
2013	358.82 Million USD	9.98%
2012	326.25 Million USD	10.92%
2011	294.13 Million USD	2.99%
2010	285.58 Million USD	14.78%
2009	248.8 Million USD	14.33%
2008	217.62 Million USD	19.13%
2007	182.68 Million USD	12.28%
2006	162.69 Million USD	149.64%
2005	65.17 Million USD	-6.03%
2004	69.35 Million USD	185.58%
2003	24.28 Million USD	20.25%
2002	20.19 Million USD	0.0%
1999	300 Thousand USD	123.08%
1998	-1.3 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q3	263.2 Million USD	3.3%
2024 Q1	241.7 Million USD	-7.99%
2024 Q2	254.8 Million USD	5.42%
2023 Q4	262.7 Million USD	11.88%
2023 Q3	234.8 Million USD	6.15%
2023 Q1	284.8 Million USD	-9.13%
2023 Q2	221.2 Million USD	-22.33%
2023 FY	1 Billion USD	-5.22%
2022 Q4	313.4 Million USD	10.94%
2022 Q1	204.76 Million USD	-4.71%
2022 Q2	258.2 Million USD	26.1%
2022 Q3	282.5 Million USD	9.41%
2022 FY	1.05 Billion USD	30.98%
2021 Q2	192.91 Million USD	-2.01%
2021 Q1	196.87 Million USD	5.32%
2021 FY	808.34 Million USD	8.79%
2021 Q3	203.66 Million USD	5.57%
2021 Q4	214.89 Million USD	5.51%
2020 FY	743.06 Million USD	18.1%
2020 Q4	186.92 Million USD	4.47%
2020 Q3	178.92 Million USD	-6.61%
2020 Q2	191.58 Million USD	3.21%
2020 Q1	185.62 Million USD	11.21%
2019 Q3	156.26 Million USD	1.25%
2019 FY	629.17 Million USD	9.44%
2019 Q1	151.64 Million USD	2.23%
2019 Q2	154.33 Million USD	1.78%
2019 Q4	166.92 Million USD	6.82%
2018 Q3	140.75 Million USD	-0.98%
2018 FY	574.89 Million USD	7.44%
2018 Q1	143.66 Million USD	-6.63%
2018 Q2	142.14 Million USD	-1.05%
2018 Q4	148.33 Million USD	5.38%
2017 Q2	128.43 Million USD	3.47%
2017 Q4	153.86 Million USD	19.58%
2017 Q1	124.13 Million USD	-0.16%
2017 FY	535.1 Million USD	15.37%
2017 Q3	128.66 Million USD	0.18%
2016 FY	463.79 Million USD	13.13%
2016 Q3	110.12 Million USD	-4.35%
2016 Q1	114.21 Million USD	12.25%
2016 Q2	115.13 Million USD	0.81%
2016 Q4	124.32 Million USD	12.9%
2015 FY	409.98 Million USD	4.91%
2015 Q4	101.74 Million USD	-0.48%
2015 Q3	102.23 Million USD	-0.65%
2015 Q2	102.9 Million USD	-0.2%
2015 Q1	103.1 Million USD	-5.55%
2014 Q3	96.22 Million USD	3.36%
2014 Q1	92.3 Million USD	1.95%
2014 Q4	109.15 Million USD	13.44%
2014 FY	390.77 Million USD	8.9%
2014 Q2	93.09 Million USD	0.86%
2013 Q4	90.53 Million USD	3.49%
2013 Q3	87.47 Million USD	-4.11%
2013 Q2	91.23 Million USD	1.84%
2013 FY	358.82 Million USD	9.98%
2013 Q1	89.58 Million USD	2.75%
2012 Q3	78.33 Million USD	-3.81%
2012 FY	326.25 Million USD	10.92%
2012 Q4	87.18 Million USD	11.3%
2012 Q1	79.3 Million USD	7.73%
2012 Q2	81.43 Million USD	2.68%
2011 Q1	76.83 Million USD	3.65%
2011 Q3	68.43 Million USD	-9.05%
2011 Q4	73.61 Million USD	7.56%
2011 FY	294.13 Million USD	2.99%
2011 Q2	75.25 Million USD	-2.06%
2010 Q4	74.12 Million USD	3.51%
2010 FY	285.58 Million USD	14.78%
2010 Q1	69.53 Million USD	5.65%
2010 Q3	71.61 Million USD	1.86%
2010 Q2	70.3 Million USD	1.1%
2009 Q1	60.74 Million USD	3.79%
2009 Q4	65.81 Million USD	5.74%
2009 Q3	62.24 Million USD	3.75%
2009 FY	248.8 Million USD	14.33%
2009 Q2	59.99 Million USD	-1.24%
2008 Q1	49.98 Million USD	1.4%
2008 Q4	58.52 Million USD	5.01%
2008 Q3	55.73 Million USD	4.45%
2008 Q2	53.36 Million USD	6.75%
2008 FY	217.62 Million USD	19.13%
2007 Q3	45.56 Million USD	-0.42%
2007 Q1	42.05 Million USD	-27.92%
2007 Q2	45.76 Million USD	8.82%
2007 FY	182.68 Million USD	12.28%
2007 Q4	49.3 Million USD	8.19%
2006 FY	162.69 Million USD	149.64%
2006 Q2	58.34 Million USD	18.33%
2006 Q3	58.34 Million USD	0.0%
2006 Q4	58.34 Million USD	0.0%
2006 Q1	49.3 Million USD	82.8%
2005 Q1	26.97 Million USD	0.0%
2005 FY	65.17 Million USD	-6.03%
2005 Q2	26.97 Million USD	0.0%
2005 Q3	26.97 Million USD	0.0%
2005 Q4	26.97 Million USD	-0.0%
2004 FY	69.35 Million USD	185.58%
2003 FY	24.28 Million USD	20.25%
2002 FY	20.19 Million USD	0.0%
1999 Q3	200 Thousand USD	0.0%
1999 FY	300 Thousand USD	123.08%
1999 Q4	100 Thousand USD	-50.0%
1998 FY	-1.3 Million USD	0.0%

Peer Gross Profit Comparison of Masimo Corporation

Name	Gross Profit	Gross Profit Difference
Phreesia, Inc.	201.74 Million USD	-397.41%
Accuray Incorporated	143.12 Million USD	-601.155%
Align Technology, Inc.	2.72 Billion USD	63.109%
Elevance Health Inc.	47.01 Billion USD	97.865%
AxoGen, Inc.	127.87 Million USD	-684.757%
Boston Scientific Corporation	9.84 Billion USD	89.811%
CVS Health Corporation	54.43 Billion USD	98.156%
Cardinal Health, Inc.	7.41 Billion USD	86.465%
Centene Corporation	153.99 Billion USD	99.348%
DaVita Inc.	3.82 Billion USD	73.733%
HCA Healthcare, Inc.	55.06 Billion USD	98.178%
Hologic, Inc.	2.23 Billion USD	55.157%
Humana Inc.	106.44 Billion USD	99.057%
IDEXX Laboratories, Inc.	2.18 Billion USD	54.177%
Laboratory Corporation of America Holdings	3.36 Billion USD	70.177%
McKesson Corporation	12.58 Billion USD	92.026%
Patterson Companies, Inc.	1.38 Billion USD	27.295%
Quest Diagnostics Incorporated	2.96 Billion USD	66.109%
ResMed Inc.	2.6 Billion USD	61.534%
Henry Schein, Inc.	3.65 Billion USD	72.514%
Teladoc Health, Inc.	1.84 Billion USD	45.533%
Universal Health Services, Inc.	1.17 Billion USD	14.623%
Veeva Systems Inc.	1.68 Billion USD	40.494%
Baxter International Inc.	4.97 Billion USD	79.829%
Becton, Dickinson and Company	8.82 Billion USD	88.626%
Intuitive Surgical, Inc.	4.72 Billion USD	78.782%
Danaher Corporation	14.12 Billion USD	92.898%
Stryker Corporation	13.05 Billion USD	92.315%
Medtronic plc	21.27 Billion USD	95.283%

Global Stocks Search

Masimo Corporation (0JZ2.L)

Gross Profit Summary of Masimo Corporation

Annual Gross Profit Chart of Masimo Corporation (2023 - 1998)

Historical Annual Gross Profit of Masimo Corporation (2023 - 1998)

Peer Gross Profit Comparison of Masimo Corporation